Serveur d'exploration MERS - Corpus (PubMed)

Index « MedMesh.i » - entrée « Drug Discovery »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Development < Drug Discovery < Drug Dosage Calculations  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]
Ident.Authors (with country if any)Title
000431 (2019) Chuanyan Wu ; Rui Gao ; Yusen Zhang ; Yang De MarinisPTPD: predicting therapeutic peptides by deep learning and word2vec.
000617 (2019) Allison L. Totura ; Sina BavariBroad-spectrum coronavirus antiviral drug discovery.
000702 (2018) Ruiying Liang ; Lili Wang ; Naru Zhang ; Xiaoqian Deng ; Meng Su ; Yudan Su ; Lanfang Hu ; Chen He ; Tianlei Ying ; Shibo Jiang ; Fei YuDevelopment of Small-Molecule MERS-CoV Inhibitors.
000789 (2018) Chao Wang ; Lei Zhao ; Shuai Xia ; Tianhong Zhang ; Ruiyuan Cao ; Guodong Liang ; Yue Li ; Guangpeng Meng ; Weicong Wang ; Weiguo Shi ; Wu Zhong ; Shibo Jiang ; Keliang LiuDe Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.
000798 (2018) Gregory W. Daniel ; Monika Schneider ; Marianne Hamilton Lopez ; Mark B. McclellanImplementation of a Market Entry Reward within the United States.
000891 (2018) Jin Soo Shin ; Eunhye Jung ; Meehyein Kim ; Ralph S. Baric ; Yun Young GoSaracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro.
000997 (2018) Chao Wang ; Shuai Xia ; Peiyu Zhang ; Tianhong Zhang ; Weicong Wang ; Yangli Tian ; Guangpeng Meng ; Shibo Jiang ; Keliang LiuDiscovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.
000A79 (2017) Yujia Jin ; Cheng Lei ; Dan Hu ; Dimiter S. Dimitrov ; Tianlei YingHuman monoclonal antibodies as candidate therapeutics against emerging viruses.
000B04 (2017) Katie Ewer ; Sarah Sebastian ; Alexandra J. Spencer ; Sarah Gilbert ; Adrian V S. Hill ; Teresa LambeChimpanzee adenoviral vectors as vaccines for outbreak pathogens.
000B53 (2017) Yaping Sun ; Huaidong Zhang ; Jian Shi ; Zhe Zhang ; Rui GongIdentification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
000B71 (2017) Woo-Jin Shin ; Baik Lin SeongType II transmembrane serine proteases as potential target for anti-influenza drug discovery.
000B80 (2017) Joel N. MaslowVaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
000D19 (2017) Nisreen Ma Okba ; V Stalin Raj ; Bart L. HaagmansMiddle East respiratory syndrome coronavirus vaccines: current status and novel approaches.
000D35 (2017) Stanley A. PlotkinVaccines for epidemic infections and the role of CEPI.
000D72 (2017) Vathan Kumar ; Jin Soo Shin ; Jiun-Jie Shie ; Keun Bon Ku ; Chonsaeng Kim ; Yun Young Go ; Kai-Fa Huang ; Meehyein Kim ; Po-Huang LiangIdentification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors.
001021 (2016) Qihui Wang ; Gary Wong ; Guangwen Lu ; Jinghua Yan ; George F. GaoMERS-CoV spike protein: Targets for vaccines and therapeutics.
001054 (2016) Kayvon Modjarrad ; Vasee S. Moorthy ; Peter Ben Embarek ; Maria Van Kerkhove ; Jerome Kim ; Marie-Paule KienyA roadmap for MERS-CoV research and product development: report from a World Health Organization consultation.
001158 (????) Raymond Taylor ; Pravin Kotian ; Travis Warren ; Rekha Panchal ; Sina Bavari ; Justin Julander ; Sylvia Dobo ; Angela Rose ; Yahya El-Kattan ; Brian Taubenheim ; Yarlagadda Babu ; William P. SheridanBCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease.
001204 (2016) Lanying Du ; Wanbo Tai ; Yusen Zhou ; Shibo JiangVaccines for the prevention against the threat of MERS-CoV.
001237 (2016) Haofeng Wang ; Song Xue ; Haitao Yang ; Cheng ChenRecent progress in the discovery of inhibitors targeting coronavirus proteases.
001264 (2016) Alimuddin Zumla ; Jasper F W. Chan ; Esam I. Azhar ; David S C. Hui ; Kwok-Yung YuenCoronaviruses - drug discovery and therapeutic options.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Drug Discovery" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Drug Discovery" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Drug Discovery
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021